Cited by 481Liver Disease Diagnosis and TreatmentLiver Diseases and ImmunityLiver physiology and pathology

The DOI matches its Crossref record.

Nonalcoholic Steatohepatitis

Elizabeth M. Brunt·2004·Seminars in Liver Disease

DOI 10.1055/s-2004-823098

Open this paper in CoChat — free account

Abstract

Nonalcoholic fatty liver disease (NAFLD) is being increasingly recognized as a common liver disorder that represents the hepatic manifestation of the metabolic syndrome, a variably defined aggregate of disorders related to obesity, insulin resistance, type II diabetes, hypertension and hyperlipidemia. Nonalcoholic steatohepatitis (NASH) is the progressive form of liver injury that carries a risk for progressive fibrosis, cirrhosis, and end-stage liver disease. Hepatocellular carcinoma (HCC) is a documented complication in an as yet unknown percentage of cases of NASH cirrhosis. The diagnosis of nonalcoholic steatohepatitis requires histopathologic evaluation because the lesions of parenchymal injury and fibrosis cannot be detected by imaging studies or laboratory tests. This article will briefly discuss prevalence studies and the pathophysiology of NAFLD and focus on current discussions related to the specific lesions in the pathology of NASH, including the challenges of pediatric NASH and NASH-related cirrhosis.

Integrity signals

Registry

Crossref · 10.1055/s-2004-823098

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Sorted by citations

Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
Kleiner, D. E., Brunt, E. M., Van Natta, M., Behling, C., Contos, M. J., Cummings, O. W., Ferrell, L. D., Liu, Y., Torbenson, M. S., Unalp‐Arida, A., et al. (2005) · Hepatology · doi:10.1002/hep.20701 · Cited by 10,791
Self-citation
NAFLD: A multisystem disease
Byrne, C. D., & Targher, G. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2014.12.012 · Cited by 3,162
The Natural History of Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study
Adams, L. A., Lymp, J. F., St. Sauver, J., Sanderson, S. O., Lindor, K. D., Feldstein, A., & Angulo, P. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.04.014 · Cited by 2,890
Prevalence of Fatty Liver in Children and Adolescents
Schwimmer, J. B., Deutsch, R., Kahen, T., Lavine, J. E., Stanley, C. R., & Behling, C. A. (2006) · PEDIATRICS · doi:10.1542/peds.2006-1212 · Cited by 1,477
JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice
Prepared, B. (2005) · Heart · doi:10.1136/hrt.2005.079988 · Cited by 1,223
Alzheimer’s disease is type 3 diabetes—Evidence reviewed
de la Monte, S. M., & Wands, J. R. (2008) · Journal of Diabetes Science and Technology · doi:10.1177/193229680800200619 · Cited by 1,158
Nonalcoholic Fatty Liver Disease: Pathology and Pathogenesis
Tiniakos, D. G., Vos, M. B., & Brunt, E. M. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-121808-102132 · Cited by 870
Self-citation
Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ
Iredale, J. P. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30542 · Cited by 866
Epidemiology of gallbladder stone disease
Shaffer, E. A. (2006) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2006.05.004 · Cited by 799
The ratio of phosphatidylcholine to phosphatidylethanolamine influences membrane integrity and steatohepatitis.
Li, Z., Agellon, L., Allen, T., Umeda, M., Jewell, L. S., Mason, A., & Vance, D. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.03.007 · Cited by 739
Mouse models in non‐alcoholic fatty liver disease and steatohepatitis research
Anstee, Q. M., & Goldin, R. D. (2006) · International Journal of Experimental Pathology · doi:10.1111/j.0959-9673.2006.00465.x · Cited by 714
Randomized, placebo-controlled trial of pioglitazone in nondiabetic subjects with nonalcoholic steatohepatitis
Aithal, G. P., Thomas, J. A., Kaye, P. V., Lawson, A., Ryder, S. D., Spendlove, I., Austin, A. S., Freeman, J. G., Morgan, L., & Webber, J. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.06.047 · Cited by 721
PAI‐1 in tissue fibrosis
Ghosh, A. K., & Vaughan, D. E. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.22783 · Cited by 701
Clinical Features and Natural History of Nonalcoholic Steatosis Syndromes
Falck-Ytter, Y. T., Younossi, Z. M., Marchesini, G., & McCullough, A. J. (2001) · Seminars in Liver Disease · doi:10.1055/s-2001-12926 · Cited by 668
Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis
George, D. K., Goldwurm, S., Macdonald, G. A., Cowley, L. L., Walker, N. I., Ward, P. J., Jazwinska, E. C., & Powell, L. W. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70482-2 · Cited by 653
Serum levels of immunoglobulins (IgG, IgA, IgM) in a general adult population and their relationship with alcohol consumption, smoking and common metabolic abnormalities.
Gonzalez-Quintela, A., Alende, R., Gude, F., Campos, J., Rey, J., Meijide, L. M., Fernandez-Merino, C., & Vidal, C. (2007) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2007.03545.x · Cited by 630
Mitochondrial free cholesterol loading sensitizes to TNF- and Fas-mediated steatohepatitis
Marí, M., Caballero, F. G., Colell, A., Morales, A., Caballería, J., Fernandez, A., Enrich, C., Fernández-Checa, J. C., & García‐Ruiz, C. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.07.006 · Cited by 624
Deletion of NEMO/IKKγ in Liver Parenchymal Cells Causes Steatohepatitis and Hepatocellular Carcinoma
Luedde, T., Beraza, N., Kotsikoris, V., Loo, G., Nenci, A., Vos, R. D., Roskams, T., Trautwein, C., & Pasparakis, M. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.12.016 · Cited by 603
Glutathione and mitochondria
Ribas, V., García‐Ruiz, C., & Fernández-Checa, J. C. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00151 · Cited by 585
Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis in the United States and the Rest of the World
Sayiner, M., Koenig, A., Henry, L., & Younossi, Z. M. (2016) · Clinics in Liver Disease · doi:10.1016/j.cld.2015.10.001 · Cited by 529
Prevalence and associated factors of non‐alcoholic fatty liver disease in patients with type‐2 diabetes mellitus
Leite, N. C., Salles, G. F., Araujo, A. L. E., Villela‐Nogueira, C. A., & Cardoso, C. R. L. (2009) · Liver International · doi:10.1111/j.1478-3231.2008.01718.x · Cited by 531
Chemotherapy-associated hepatotoxicity and surgery for colorectal liver metastases
Zorzi, D., Laurent, A., Pawlik, T. M., Lauwers, G. Y., Vauthey, J.-N., & Abdalla, E. K. (2007) · British journal of surgery · doi:10.1002/bjs.5719 · Cited by 532
In situ detection of lipid peroxidation and oxidative DNA damage in non-alcoholic fatty liver diseases
Seki, S., Kitada, T., Yamada, T., Sakaguchi, H., Nakatani, K., & Wakasa, K. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00073-9 · Cited by 536
World Gastroenterology Organisation Global Guidelines
LaBrecque, D. R., Abbas, Z., Anania, F. A., Ferenci, P., Khan, A. G., Goh, K., Hamid, S. S., Va, I., Lizarzábal, M., Peñaranda, M. M., et al. (2014) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000000116 · Cited by 524
Fat quantification with IDEAL gradient echo imaging: Correction of bias from T 1 and noise
Liu, C., McKenzie, C. A., Yu, H., Brittain, J. H., & Reeder, S. B. (2007) · Magnetic Resonance in Medicine · doi:10.1002/mrm.21301 · Cited by 477
Histopathology of nonalcoholic fatty liver disease
Brunt, E. M. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i42.5286 · Cited by 448
Self-citation
Exposure to per- and polyfluoroalkyl substances and markers of liver injury: a systematic review and meta-analysis
Costello, E., Rock, S., Stratakis, N., Eckel, S. P., Walker, D. I., Valvi, D., Cserbik, D., Jenkins, T., Xanthakos, S. A., Kohli, R., et al. (2022) · Environmental Health Perspectives · doi:10.1289/ehp10092 · Cited by 420
Prolonged n‐3 polyunsaturated fatty acid supplementation ameliorates hepatic steatosis in patients with non‐alcoholic fatty liver disease: a pilot study
Capanni, M., Calella, F., Biagini, M. R., Genise, S., Raimondi, L., Bedogni, G., Svegliati‐Baroni, G., Sofi, F., Milani, S., Abbate, R., et al. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.02885.x · Cited by 412
Ninety patients with nonalcoholic steatohepatitis: insulin resistance, familial tendency, and severity of disease
Willner, I. R., Waters, B., Patil, S. R., Reuben, A., Morelli, J., & Riely, C. A. (2001) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2001.04667.x · Cited by 419
From Mallory to Mallory–Denk bodies: What, how and why?
Zatloukal, K., French, S. W., Stumptner, C., Strnad, P., Harada, M., Toivola, D. M., Cadrin, M., & Omary, M. B. (2007) · Experimental Cell Research · doi:10.1016/j.yexcr.2007.04.024 · Cited by 342
Autophagy and Lipid Droplets in the Liver
Martínez-López, N., & Singh, R. (2015) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071813-105336 · Cited by 345
Correlation of paired liver biopsies in morbidly obese patients with suspected nonalcoholic fatty liver disease†
Merriman, R. B., Ferrell, L. D., Patti, M. G., Weston, S. R., Pabst, M. S., Aouizerat, B. E., & Bass, N. M. (2006) · Hepatology · doi:10.1002/hep.21346 · Cited by 325
Epidemiology and natural history of non-alcoholic fatty liver disease (NAFLD)
Bellentani, S., & Marino, M. (2009) · Annals of Hepatology · doi:10.1016/s1665-2681(19)31820-4 · Cited by 322
Clinical features and outcomes of cirrhosis due to non‐alcoholic steatohepatitis compared with cirrhosis caused by chronic hepatitis C
Yatsuji, S., Hashimoto, E., Tobari, M., Taniai, M., Tokushige, K., & Shiratori, K. (2008) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2008.05640.x · Cited by 318
Update on Nonalcoholic Fatty Liver Disease
McCullough, A. J. (2002) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-200203000-00013 · Cited by 316
Surgery for morbid obesity
Colquitt, J. L., Clegg, A. J., Loveman, E., Royle, P., & Sidhu, M. K. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003641.pub2 · Cited by 337
Hepatic steatosis in obese Chinese children
Chan, D., Li, C. K., Chu, C. W., Chan, M. H. M., Wong, E. M. C., Liu, E. K. H., Chan, I. H.-S., Yin, J., Lam, C. W. K., Fok, T. F., et al. (2004) · International Journal of Obesity · doi:10.1038/sj.ijo.0802734 · Cited by 296
Bariatric surgery for non-alcoholic steatohepatitis in obese patients
Chávez-Tapia, N. C., Téllez-Ávila, F. I., Barrientos‐Gutiérrez, T., Méndez‐Sánchez, N., Lizardi-Cervera, J., & Uribe, M. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007340.pub2 · Cited by 301
Interleukin-17 exacerbates hepatic steatosis and inflammation in non-alcoholic fatty liver disease
Tang, Y., Bian, Z., Zhao, L., Liu, Y., Liang, S., Wang, Q., Han, X., Peng, Y., Chen, X., Shen, L., et al. (2011) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2011.04471.x · Cited by 294
Prevalence of primary non‐alcoholic fatty liver disease in a population‐based study and its association with biochemical and anthropometric measures
Zelber‐Sagi, S., Nitzan, D., Halpern, Z., & Oren, R. (2006) · Liver International · doi:10.1111/j.1478-3231.2006.01311.x · Cited by 291
Diagnostic Value of a Computerized Hepatorenal Index for Sonographic Quantification of Liver Steatosis
Webb, M., Yeshua, H., Zelber‐Sagi, S., Santo, E., Brazowski, E., Halpern, Z., & Oren, R. (2009) · American Journal of Roentgenology · doi:10.2214/ajr.07.4016 · Cited by 292
Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals
Masuoka, H. C., & Chalasani, N. (2013) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12016 · Cited by 290
Association of Cardiorespiratory Fitness, Body Mass Index, and Waist Circumference to Nonalcoholic Fatty Liver Disease
Church, T. S., Kuk, J. L., Ross, R., Priest, E. L., Biltoff, E., & Blair, S. N. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.03.019 · Cited by 268
Silybin combined with phosphatidylcholine and vitamin E in patients with nonalcoholic fatty liver disease: A randomized controlled trial
Loguercio, C., Andreoné, P., Brisc, C., Brisc, M. C., Bugianesi, E., Chiaramonte, M., Cursaro, C., Dănilă, M., de Sio, I., Floreani, A., et al. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.02.008 · Cited by 270
Alcoholic liver disease: proposed recommendations for the American College of Gastroenterology
McCullough, A. J., & O’Connor, B. J. F. (1998) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1998.00587.x · Cited by 268
Preoperative Chemotherapy for Colorectal Liver Metastases: Impact on Hepatic Histology and Postoperative Outcome
Pawlik, T. M., Olino, K. L., Gleisner, A., Torbenson, M. S., Schulick, R. D., & Choti, M. A. (2007) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-007-0149-4 · Cited by 260
Nonalcoholic fatty liver disease: An agenda for clinical research
Younossi, Z. M., Diehl, A. M., & Ong, J. P. (2002) · Hepatology · doi:10.1053/jhep.2002.32483 · Cited by 260
Report of the National Heart, Lung, and Blood Institute-National Institute of Diabetes and Digestive and Kidney Diseases Working Group on the Pathophysiology of Obesity-Associated Cardiovascular Disease
Eckel, R. H., Barouch, W. W., & Ershow, A. G. (2002) · Circulation · doi:10.1161/01.cir.0000017823.53114.4c · Cited by 257
A Model of Insulin Resistance and Nonalcoholic Steatohepatitis in Rats
Svegliati‐Baroni, G., Candelaresi, C., Saccomanno, S., Ferretti, G., Bachetti, T., Marzioni, M., Minicis, S. D., Nobili, L., Salzano, R., Omenetti, A., et al. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.050953 · Cited by 258
Mitochondria: a hub of redox activities and cellular distress control
Kakkar, P., & Singh, B. K. (2007) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-007-9520-8 · Cited by 255
Longitudinal analysis of murine steatohepatitis model induced by chronic exposure to high‐fat diet
Ito, M., Suzuki, J., Tsujioka, S., Sasaki, M., Gomori, A., Shirakura, T., Hirose, H., Ito, M., Ishihara, A., Iwaasa, H., et al. (2007) · Hepatology Research · doi:10.1111/j.1872-034x.2007.00008.x · Cited by 263
Relationship of steatosis grade and zonal location to histological features of steatohepatitis in adult patients with non-alcoholic fatty liver disease
Chalasani, N., Wilson, L., Kleiner, D. E., Cummings, O. W., Brunt, E. M., & Ünalp, A. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.01.016 · Cited by 260
Self-citation
Oxidative Stress and Inflammation in Hepatic Diseases: Therapeutic Possibilities of N-Acetylcysteine
de Andrade, K. Q., Moura, F. A., dos Santos, J. M., de Araújo, O. R. P., Santos, J. D. F., & Goulart, M. O. F. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161226225 · Cited by 258
BNip3 Regulates Mitochondrial Function and Lipid Metabolism in the Liver
Glick, D., Zhang, W., Beaton, M., Marsboom, G., Gruber, M., Simon, M. C., Hart, J., Dorn, G. W., Brady, M. J., & Macleod, K. F. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.00167-12 · Cited by 251
Plasma total and free fatty acids composition in human non-alcoholic steatohepatitis
TAVARES DE ALMEIDA, I., CORTEZ-PINTO, H., FIDALGO, G., RODRIGUES, D., & CAMILO, M. E. (2002) · Clinical Nutrition · doi:10.1054/clnu.2001.0529 · Cited by 243
Critical role of cytochrome P450 2E1 (CYP2E1) in the development of high fat-induced non-alcoholic steatohepatitis
Abdelmegeed, M. A., Banerjee, A., Yoo, S.-H., Jang, S., Gonzalez, F. J., & Song, B. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.05.019 · Cited by 247
Ballooned hepatocytes in steatohepatitis: The value of keratin immunohistochemistry for diagnosis
Lackner, C., Gogg-Kamerer, M., Zatloukal, K., Stumptner, C., Brunt, E. M., & Denk, H. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.01.026 · Cited by 240
Self-citation
Pathology of fatty liver disease
Brunt, E. M. (2007) · Modern Pathology · doi:10.1038/modpathol.3800680 · Cited by 238
Self-citation
Effects of bezafibrate, PPAR pan-agonist, and GW501516, PPARδ agonist, on development of steatohepatitis in mice fed a methionine- and choline-deficient diet
Nagasawa, T., Inada, Y., Nakano, S., Tamura, T., Takahashi, T., Maruyama, K., Yamazaki, Y., Kuroda, J., & Shibata, N. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.02.028 · Cited by 233
Serum metabolomics reveals γ-glutamyl dipeptides as biomarkers for discrimination among different forms of liver disease
Soga, T., Sugimoto, M., Honma, M., Mori, M., Igarashi, K., Kashikura, K., Ikeda, S., Hirayama, A., Yamamoto, T., Yoshida, H., et al. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2011.01.031 · Cited by 235
Medical consequences of obesity
Lawrence, V., & Kopelman, P. G. (2004) · Clinics in Dermatology · doi:10.1016/j.clindermatol.2004.01.012 · Cited by 237
Altered expression of fatty acid–metabolizing enzymes in aromatase-deficient mice
Nemoto, Y., Toda, K., Ono, M., Fujikawa‐Adachi, K., Saibara, T., Onishi, S., Enzan, H., Okada, T., & Shizuta, Y. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9575 · Cited by 230
Non‐alcoholic fatty liver disease: An overview
Mulhall, B. P., Ong, J. P., & Younossi, Z. M. (2002) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.2002.02881.x · Cited by 227
Leptin reverses nonalcoholic steatohepatitis in patients with severe lipodystrophy†
Javor, E. D., Ghany, M. G., Cochran, E. K., Oral, E. A., DePaoli, A. M., Premkumar, A., Kleiner, D. E., & Gorden, P. (2005) · Hepatology · doi:10.1002/hep.20672 · Cited by 228
Prevalence of non-alcoholic fatty liver disease in urban south Indians in relation to different grades of glucose intolerance and metabolic syndrome
Mohan, V., Syed, F., Deepa, M., Ravikumar, R., & Pitchumoni, C. S. (2009) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2008.11.039 · Cited by 226
T1 independent, T2* corrected MRI with accurate spectral modeling for quantification of fat: Validation in a fat‐water‐SPIO phantom
Hines, C. D. G., Yu, H., Shimakawa, A. S., McKenzie, C. A., Brittain, J. H., & Reeder, S. B. (2009) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.21957 · Cited by 221
Role of Radiologic Modalities in the Management of Non-alcoholic Steatohepatitis
Charatcharoenwitthaya, P., & Lindor, K. D. (2007) · Clinics in Liver Disease · doi:10.1016/j.cld.2007.02.014 · Cited by 218
Serum thioredoxin levels as a predictor of steatohepatitis in patients with nonalcoholic fatty liver disease
Sumida, Y., Nakashima, T., Yoh, T., Furutani, M., Hirohama, A., Kakisaka, Y., Nakajima, Y., Ishikawa, H., Mitsuyoshi, H., Okanoue, T., et al. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00331-8 · Cited by 216
Mitochondrial glutathione: Features, regulation and role in disease
Marí, M., Morales, A., Colell, A., García‐Ruiz, C., Kaplowitz, N., & Fernández-Checa, J. C. (2012) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2012.10.018 · Cited by 207
T 1 independent, T 2 * corrected chemical shift based fat–water separation with multi‐peak fat spectral modeling is an accurate and precise measure of hepatic steatosis
Hines, C. D. G., Frydrychowicz, A. P., Hamilton, G., Tudorascu, D., Vigen, K. K., Yu, H., McKenzie, C. A., Sirlin, C. B., Brittain, J. H., & Reeder, S. B. (2011) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.22514 · Cited by 202
A simple clinical scoring system using ferritin, fasting insulin, and type IV collagen 7S for predicting steatohepatitis in nonalcoholic fatty liver disease
Japan Study Group of Nonalcoholic Fatty Liver Disease (JSG-NAFLD), Sumida, Y., Yoneda, M., Hyogo, H., Yamaguchi, K., Ono, M., Fujii, H., Eguchi, Y., Suzuki, Y., Imai, S., et al. (2010) · Journal of Gastroenterology · doi:10.1007/s00535-010-0305-6 · Cited by 200
Nonalcoholic Steatohepatitis and the Metabolic Syndrome
Neuschwander‐Tetri, B. A. (2005) · The American Journal of the Medical Sciences · doi:10.1097/00000441-200512000-00011 · Cited by 195
Advanced MRI Methods for Assessment of Chronic Liver Disease
Taouli, B. A., Ehman, R. L., & Reeder, S. B. (2009) · American Journal of Roentgenology · doi:10.2214/ajr.09.2601 · Cited by 199
Non-alcoholic steatohepatitis: From cell biology to clinical practice
Cortez‐Pinto, H., de Moura, M. C., & Day, C. P. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.09.002 · Cited by 194
The epidemiology, pathogenesis and histopathology of fatty liver disease
Levene, A., & Goldin, R. D. (2012) · Histopathology · doi:10.1111/j.1365-2559.2011.04145.x · Cited by 195
Non‐alcoholic fatty liver syndrome: A hepatic consequence of common metabolic diseases
Angelico, F., Ben, M. D., Conti, R., Francioso, S., Feole, K., Maccioni, D., Antonini, T., & Alessandri, C. (2003) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.2003.02958.x · Cited by 189
Non-alcoholic fatty liver disease in an area of southern Italy: main clinical, histological, and pathophysiological aspects.
Loguercio, C., Girolamo, V. D., de Sio, I., Tuccillo, C., Ascione, A., Baldi, F., Budillon, G., Cimino, L., Carlo, A. D., Marino, M. D. D., et al. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00192-1 · Cited by 186
A pilot study of atorvastatin treatment in dyslipemid, non‐alcoholic fatty liver patients
GÓMEZ‐DOMÍNGUEZ, E., Gisbert, J. P., Moreno-Monteagudo, J. A., Garcı́a-Buey, L., & Moreno‐Otero, R. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.02926.x · Cited by 189
Mice Heterozygous for a Defect in Mitochondrial Trifunctional Protein Develop Hepatic Steatosis and Insulin Resistance
Ibdah, J. A., Perlegas, P., Zhao, Y., Angdisen, J., Borgerink, H., Shadoan, M. K., Wagner, J. D., Matern, D., Rinaldo, P., & Cline, J. M. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.02.001 · Cited by 186
Current concepts in the pathogenesis of nonalcoholic fatty liver disease
Méndez‐Sánchez, N., Arrese, M. A., Zamora‐Valdés, D., & Uribe, M. (2007) · Liver International · doi:10.1111/j.1478-3231.2007.01483.x · Cited by 189
Hepatocellular carcinoma in non-alcoholic steatohepatitis: Current knowledge and implications for management
Cholankeril, G. T., Patel, R., Khurana, S., & Satapathy, S. K. (2017) · World Journal of Hepatology · doi:10.4254/wjh.v9.i11.533 · Cited by 185
Prevalence and etiology of altered liver tests
Pendino, G. M., Mariano, A., Surace, P., Caserta, C. A., Fiorillo, M. T., Amante, A., Bruno, S., Mangano, C., Polito, I., Amato, F., et al. (2005) · Hepatology · doi:10.1002/hep.20689 · Cited by 178
Heme oxygenase-1 levels and oxidative stress-related parameters in non-alcoholic fatty liver disease patients
Malaguarnera, L., Madeddu, R., Palio, E., Arena, N., & Malaguarnera, M. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2004.11.040 · Cited by 174
Histopathology of Non-Alcoholic Fatty Liver Disease
Brunt, E. M. (2009) · Clinics in Liver Disease · doi:10.1016/j.cld.2009.07.008 · Cited by 170
Self-citation
Comparison of the Phenotype and Approach to Pediatric vs Adult Patients With Nonalcoholic Fatty Liver Disease
Nobili, V., Alisi, A., Newton, K. P., & Schwimmer, J. B. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.03.009 · Cited by 174
Quantitative magnetic resonance imaging of hepatic steatosis: Validation in ex vivo human livers
Bannas, P., Kramer, H., Hernando, D., Agni, R. M., Cunningham, A. M., Mandal, R., Motosugi, U., Sharma, S. D., del Río, A. M., Fernandez, L. A., et al. (2015) · Hepatology · doi:10.1002/hep.28012 · Cited by 170
COX‐2 induction in mice with experimental nutritional steatohepatitis
Yu, J. Q., Ip, E., Peňa, A. D., Hou, J. Y., Sesha, J., Pera, N., Hall, P. D. L. Μ., Kirsch, R., Leclercq, I. A., & Farrell, G. C. (2006) · Hepatology · doi:10.1002/hep.21108 · Cited by 172
Increased severity of alcoholic liver injury in female rats: role of oxidative stress, endotoxin, and chemokines
Nanji, A. A., Jokelainen, K., Fotouhinia, M., Rahemtulla, A., Thomas, P., Tipoe, G. L., Su, G. L., & Dannenberg, A. J. (2001) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.2001.281.6.g1348 · Cited by 161
Liver transplantation and non-alcoholic fatty liver disease
Zezos, P. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i42.15532 · Cited by 158
Hepatitis C and steatosis: a reappraisal
Lonardo, A., Loria, P., Adinolfi, L. E., Carulli, N., & Ruggiero, G. (2005) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2005.00669.x · Cited by 156
Fatty Liver Disease
(2004) · Wiley eBooks · doi:10.1002/9780470987438 · Cited by 156
Erythrophagocytosis by Liver Macrophages (Kupffer Cells) Promotes Oxidative Stress, Inflammation, and Fibrosis in a Rabbit Model of Steatohepatitis
Otogawa, K., Kinoshita, K., Fujii, H., Sakabe, M., Shiga, R., Nakatani, K., Ikeda, K., Nakajima, Y., Ikura, Y., Ueda, M., et al. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.060441 · Cited by 153
Liver biopsy assessment in chronic viral hepatitis: a personal, practical approach
Theise, N. D. (2007) · Modern Pathology · doi:10.1038/modpathol.3800693 · Cited by 147
Obesity, Visceral Fat, and NAFLD: Querying the Role of Adipokines in the Progression of Nonalcoholic Fatty Liver Disease
Mirza, M. S. (2011) · ISRN Gastroenterology · doi:10.5402/2011/592404 · Cited by 148
PPAR/RXR Regulation of Fatty Acid Metabolism and Fatty Acidω‐Hydroxylase (CYP4) Isozymes: Implications for Prevention of Lipotoxicity in Fatty Liver Disease
Hardwick, J. P., Osei‐Hyiaman, D., Wiland, H. O., Abdelmegeed, M. A., & Song, B. (2009) · PPAR Research · doi:10.1155/2009/952734 · Cited by 148
Is weight reduction an effective therapy for nonalcoholic fatty liver?
Wang, R. T., Koretz, R. L., & Yee, H. F. (2003) · The American Journal of Medicine · doi:10.1016/s0002-9343(03)00449-2 · Cited by 146
Leptin‐mediated neovascularization is a prerequisite for progression of nonalcoholic steatohepatitis in rats†
Kitade, M., Yoshiji, H., Kojima, H., Ikenaka, Y., Noguchi, R., Kaji, K., Yoshii, J., Yanase, K., Namisaki, T., Asada, K., et al. (2006) · Hepatology · doi:10.1002/hep.21338 · Cited by 147
History of Nonalcoholic Fatty Liver Disease
Lonardo, A., Leoni, S., Alswat, K., & Fouad, Y. M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165888 · Cited by 154
Non‐alcoholic fatty liver disease as an independent manifestation of the metabolic syndrome: Results of a US national survey in three ethnic groups
Smits, M. M., Ioannou, G. N., Boyko, E. J., & Utzschneider, K. M. (2013) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.12106 · Cited by 142
Ethanol Production by Selected Intestinal Microorganisms and Lactic Acid Bacteria Growing under Different Nutritional Conditions
Elshaghabee, F. M. F., Bockelmann, W., Meske, D., de Vrese, M., Walte, H.-G., Schrezenmeir, J., & Heller, K. J. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.00047 · Cited by 144

Authors: Brunt, E. M.
Affiliations: Saint Louis University Hospital (US)
Corresponding author: Elizabeth M. Brunt
ORCID: Elizabeth M. Brunt
Venue: Seminars in Liver Disease
Publisher: Georg Thieme Verlag KG
Published: 2004-01
Volume: 24
Issue: 1
Pages: 3-20
ISSN: 0272-8087 (ISSN-L)
1098-8971
DOI: 10.1055/s-2004-823098
OpenAlex: W3149847267
Cited by: 481
References: 0
Citations by year: 2026: 2 · 2025: 2 · 2024: 9 · 2023: 8 · 2022: 4 · 2021: 6 · 2020: 13 · 2019: 4 · 2018: 18 · 2017: 14 · 2016: 24 · 2015: 25 · 2014: 26 · 2013: 22 · 2012: 31
FWCI: 29.48
Type: journal article
Language: en
Open access: closed
Locations: Seminars in Liver Disease (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
Health Sciences › Medicine › Hepatology › Liver physiology and pathology
Keywords: nonalcoholic steatohepatitis, non-alcoholic fatty liver disease, metabolic syndrome, liver fibrosis, liver cirrhosis, hepatocellular carcinoma, histopathology, pathophysiology, prevalence, insulin resistance, obesity
MeSH terms: Adolescent, Adult, Child, Fatty Liver, Fatty Liver, Alcoholic, Carcinoma, Hepatocellular, Humans, Liver Cirrhosis, Liver Neoplasms, Prevalence, Metabolic Syndrome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Nonalcoholic Steatohepatitis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cited by

Related

Metadata

Record

About these checks